Mitochondria-derived reactive oxygen species mediate heme oxygenase-1 expression in sheared endothelial cells

J Pharmacol Exp Ther. 2009 Apr;329(1):94-101. doi: 10.1124/jpet.108.145557. Epub 2009 Jan 8.

Abstract

Bovine aortic endothelial cells (ECs) respond to nitric oxide (NO) donors by activating the redox-sensitive NF-E2-related factor 2/antioxidant response element pathway and up-regulating heme oxygenase (HO)-1 expression. EC exposure to steady laminar shear stress causes a sustained increase in NO, a transient increase in reactive oxygen species (ROS), and activation of the HO-1 gene. Because steady laminar flow increases the mitochondrial superoxide (O(2)(*-)) production, we hypothesized that mitochondria-derived ROS play a role in shear-induced HO-1 expression. Flow (10 dynes/cm(2), 6 h)-induced expression of HO-1 protein was abolished when BAECs were preincubated and sheared in the presence of either N(G)-nitro-L-arginine methyl ester or N-acetyl-L-cysteine, suggesting that either NO or ROS up-regulates HO-1. Ebselen and diphenylene iodonium blocked HO-1 expression, and uric acid had no effect. The mitochondrial electron transport chain inhibitors, myxothiazol, rotenone, or antimycin A, and the mitochondria-targeted antioxidant peptide, Szeto-Schiller (SS)-31, which scavenges O(2)(*-), hydrogen peroxide (H(2)O(2)), peroxynitrite, and hydroxyl radicals, markedly inhibited the increase in HO-1 expression. These data collectively suggest that mitochondrial H(2)O(2) mediates the HO-1 induction. MitoSOX and 2',7'-dichlorofluorescin (DCF) fluorescence showed that mitochondrial O(2)(*-) levels and intracellular peroxides, respectively, are higher in sheared ECs compared with static controls and, in part, dependent on NO. SS-31 significantly inhibited both the shear-induced MitoSOX and DCF fluorescence signals. Either phosphatidylinositol 3-kinase or mitogen-activated protein kinase cascade inhibitors blocked the HO-1 induction. In conclusion, under shear, EC mitochondria-derived H(2)O(2) diffuses to the cytosol, where it initiates oxidative signaling leading to HO-1 up-regulation and maintenance of the atheroprotective EC status.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetylcysteine / pharmacology
  • Animals
  • Antioxidants / pharmacology
  • Blotting, Western
  • Cattle
  • Electron Transport / drug effects
  • Endothelial Cells / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Heme Oxygenase-1 / biosynthesis*
  • Hydrogen Peroxide / metabolism
  • In Vitro Techniques
  • Mitochondria / metabolism*
  • Mitogen-Activated Protein Kinases / metabolism
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / metabolism
  • Nitric Oxide Donors / pharmacology
  • Nitric Oxide Synthase Type III / antagonists & inhibitors
  • Phosphatidylinositol 3-Kinases / metabolism
  • Reactive Oxygen Species / metabolism*
  • Spectrometry, Fluorescence

Substances

  • Antioxidants
  • Enzyme Inhibitors
  • Nitric Oxide Donors
  • Reactive Oxygen Species
  • Nitric Oxide
  • Hydrogen Peroxide
  • Nitric Oxide Synthase Type III
  • Heme Oxygenase-1
  • Phosphatidylinositol 3-Kinases
  • Mitogen-Activated Protein Kinases
  • NG-Nitroarginine Methyl Ester
  • Acetylcysteine